Proton Pump Inhibitors: Dangerous and Habit-Forming Heartburn Drugs

Total Page:16

File Type:pdf, Size:1020Kb

Proton Pump Inhibitors: Dangerous and Habit-Forming Heartburn Drugs Health Letter SIDNEY M. WOLFE, M.D., EDITOR SEPTEMBER 2011 – VOL. 27, N o. 9 Proton Pump Inhibitors: Dangerous and Habit-Forming Heartburn Drugs obert Kuttner, co-editor of The PPIs Available in the U.S. a documented need for the therapy, and American Prospect magazine, many more could easily be switched to R Prescription PPIs had experienced a few bouts of mild safer options. heartburn, when a particularly severe Generic Name Brand Name episode sent him to the emergency dexlansoprazole Dexilant PPIs available in the U.S. room. After his doctor prescribed esomeprazole Nexium There are currently eight different Prilosec (omeprazole), a common esomeprazole and prescription PPI medications and three Vimovo* heartburn therapy, he thought that this naproxen over-the-counter medications available would resolve his condition. He never lansoprazole Prevacid on the U.S. market. (See the “PPIs imagined that this drug — intended to omeprazole Prilosec Available in the U.S.” table on this treat his symptoms — would actually omeprazole and page.) Zegerid make them worse, and that he would sodium bicarbonate Some of the FDA-approved uses become dependent for years on ever- pantoprazole Protonix for prescription PPIs are treatment of increasing doses of the medication in rabeprazole Aciphex gastric ulcers and erosive esophagitis, a dangerous cycle ending only after he and prevention of upper gastrointestinal Over the Counter PPIs stopped taking Prilosec and switched to bleeding, commonly seen with other, safer therapies. Generic Name Brand Name nonsteroidal anti-inflammatory drug This story is likely all too common omeprazole Prilosec OTC (NSAID) use. One of the most common among patients placed on a widely used omeprazole and Zegerid OTC conditions for which PPIs are prescribed class of medications known as proton sodium bicarbonate is gastroesophageal reflux disease pump inhibitors (PPIs) — Prilosec lansoprazole Prevacid 24-Hr (GERD), or heartburn. being the most common — which Many people have experienced * Vimovo is a combination of the PPI suppress stomach acid and are used to esomeprazole and the nonsteroidal anti- GERD at some point in their lives, and treat conditions such as heartburn and inflammatory drug (NSAID) naproxen. for some, it is so severe that they seek other, more severe illnesses. The drugs out, and often need, medication for have traditionally been considered petition, visit: http://www.citizen.org/ relief. But, for most, the symptoms are largely harmless by patients and petition-asking-fda-to-add-warnings- mild and fluctuate with lifestyle or diet, physicians alike. Yet PPIs have been to-ppis.) The petition was supported by and minor modifications to either could increasingly associated with a range of Mr. Kuttner and Dr. Helge Waldum, alleviate symptoms. Yet studies show dangerous, and sometimes fatal, side a physician-researcher and author of that many of these people are placed on effects and can even cause, as in Mr. 135 scientific papers, among them the PPIs unnecessarily — and once they’re Kuttner’s case, long-term dependence. first study showing that patients could see PPI, page 2 In August 2011, Public Citizen filed become dependent on PPIs. a petition with the Food and Drug The absence of prominently displayed Administration (FDA) to put black box risk information in PPI labels is likely a In This Issue warnings on all PPIs to warn doctors key contributor to the vast amount of and patients of these life-threatening overuse of the drugs, as doctors may Preventing Diabetes side effects and to remind doctors that not be aware that such serious risks exist on a Budget ........................................ 6 there are many safer alternatives for and thus resort to PPIs as a first option RECALLS ............................................ 8 everyday conditions, such as acid reflux, for even mild cases of heartburn. Most OUTRAGE! ......................................... 12 that often work just as well. (To read the patients on the drugs do not even have For more health-related news, visit our website at www.citizen.org/hrg PPI, from page 1 Nexium amid a large-scale promotional on, they may have a hard time getting campaign, with a half-billion dollars off the drugs. spent on marketing in just the first year. In response, sales predictably climbed to PUBLIC CITIZEN History and popularity astronomical levels. By 2009, Nexium of PPIs was easily the top-selling PPI and Health Letter ranked second in both retail sales ($5 PPIs first emerged on the scene in billion) and number of prescriptions SEPTEMBER 2011 the 1980s, at a time when patients filled (26.5 million) among all brand- Vol. 27, No. 9 often medicated for heartburn on an name drugs in the country. as-needed basis, using safe antacid This trend of repackaging older Editor therapies or modifying their daily PPIs in slightly modified (and much Sidney M. Wolfe, M.D. routines in ways that often worked to more expensive) forms continued relieve symptoms, such as raising the with the recent approval of Dexilant head of the bed or avoiding certain Managing Editor (dexlansoprazole — a repackaging of foods in excess. The need for long-term, Cynthia Williams Prevacid, or lansoprazole, which is now once-daily acid-suppressing therapy was available as a generic and much cheaper). relatively uncommon and reserved for Nexium and Dexilant are prime Contributors severe cases of acid reflux. Histamine-2 Sidney M. Wolfe, M.D. examples of the decreased innovation receptor antagonists (H2As) — such as seen in the pharmaceutical industry in Sammy Almashat, M.D. cimetidine (Tagamet) and ranitidine recent years, and of the desperate — (Zantac) — were the drugs of choice and wildly successful — attempts of Graphic Designer for quelling excessive acid production Erin Hyland the industry to get doctors to prescribe, in these cases. These drugs work by and patients to use, exorbitantly priced suppressing acid production in the drugs that are essentially identical to Public Citizen President stomach, but not as profoundly as do older, cheaper versions. Robert Weissman PPIs. They, therefore, carry a lower risk for serious adverse effects. Relief at a high cost However, following their intro- The Health Research Group was co- Due in large part to these duction in the U.S., PPIs rapidly rose founded in 1971 by Ralph Nader and promotional campaigns, PPI sales have in popularity over the next two decades. Sidney Wolfe in Washington, D.C., skyrocketed. But what are the costs This was due in part to their considerable to fight for the public’s health and of such widespread use? And do these effectiveness for certain serious give consumers more control over costs outweigh the benefits? conditions, such as peptic ulcer disease, decisions that affect their health. The economic cost of PPI use is high but much more so to their widespread enough, with $13.6 billion spent on the inappropriate use for indications for Annual subscription rate is drugs in one year alone (2009), making which there is no evidence of benefit $18.00 (12 issues). them the third highest-selling class of and their (incorrectly) perceived lack drugs in the country. By contrast, safer of side effects. PPI use increased more Material in the Health Letter may not H2A therapies are not even among than eight-fold from 1995 to 2006, be reprinted without permission from the 15 top-selling drug classes, not to and in 2009, there were 119 million mention the lower prices of antacids the Editor. Send requests, subscrip- prescriptions filled for the medications. and the safest of all options: diet and tion and address changes to: Contributing to this explosion in lifestyle changes. PPI use were massive promotional Unfortunately, this higher spending Health Letter campaigns and a disturbing trend of on PPIs does not confer any increase 1600 20th St. NW older PPIs being repackaged in new, in safety or, in most cases, effectiveness. Washington, DC 20009 slightly tweaked but otherwise identical As discussed below, most people with forms. Nexium (esomeprazole) is a heartburn can do just fine using safer Copyright © Health Letter, 2011 poster child of this trend. Nexium, the alternatives. Moreover, PPIs have Published monthly by Public Citizen’s so-called “purple pill,” was simply a serious safety issues not seen with other Health Research Group reformulation of a previously approved heartburn therapies. Of most concern drug, Prilosec (omeprazole), whose All rights reserved. ISSN 0882-598X to patients contemplating PPI therapy, patent was expiring around the time of due to the absence of prominent Nexium’s introduction. In 2001, drug manufacturer AstraZeneca released see PPI, page 3 2 ✦ September 2011 PPI, from page 2 In August 2011, Public Citizen filed a petition with warnings in the drugs’ labels, even the FDA to put black box warnings on all PPIs [such doctors may not be aware of these potentially fatal side effects prior to as Prilosec] to warn doctors and patients of … life- writing a prescription. threatening side effects and to remind doctors that there Furthermore, new side effects are are many safer alternatives for everyday conditions, constantly being found. In just the past such as acid reflux, that often work just as well. year and a half, the FDA has released two safety alerts warning that PPI use include safety information warning deficiency. Magnesium is an was associated with potentially fatal patients about the risk of hip, essential electrolyte, and a decrease side effects: osteoporotic fractures (of spine and wrist fractures after in levels can be life-threatening, the hip, spine and wrist) and severe using PPIs for a year or more. causing dangerous heart-rhythm magnesium deficiency. These are This announcement came after disorders and seizures. Certain two of many serious adverse reactions a review by the FDA of seven patients, especially the elderly, that have been associated with PPI large studies showing that the may be taking other medicines that therapy, as detailed in our petition and drugs were linked with a higher decrease magnesium levels (such as summarized below.
Recommended publications
  • Medicines That Affect Fluid Balance in the Body
    the bulk of stools by getting them to retain liquid, which encourages the Medicines that affect fluid bowels to push them out. balance in the body Osmotic laxatives e.g. Lactulose, Macrogol - these soften stools by increasing the amount of water released into the bowels, making them easier to pass. Older people are at higher risk of dehydration due to body changes in the ageing process. The risk of dehydration can be increased further when Stimulant laxatives e.g. Senna, Bisacodyl - these stimulate the bowels elderly patients are prescribed medicines for chronic conditions due to old speeding up bowel movements and so less water is absorbed from the age. stool as it passes through the bowels. Some medicines can affect fluid balance in the body and this may result in more water being lost through the kidneys as urine. Stool softener laxatives e.g. Docusate - These can cause more water to The medicines that can increase risk of dehydration are be reabsorbed from the bowel, making the stools softer. listed below. ANTACIDS Antacids are also known to cause dehydration because of the moisture DIURETICS they require when being absorbed by your body. Drinking plenty of water Diuretics are sometimes called 'water tablets' because they can cause you can reduce the dry mouth, stomach cramps and dry skin that is sometimes to pass more urine than usual. They work on the kidneys by increasing the associated with antacids. amount of salt and water that comes out through the urine. Diuretics are often prescribed for heart failure patients and sometimes for patients with The major side effect of antacids containing magnesium is diarrhoea and high blood pressure.
    [Show full text]
  • Mast Cell Tumor (Canine)
    MAST CELL TUMOR (CANINE) What is a mast cell tumor? A mast cell tumor is a cancer of a specific type of inflammatory cell, usually in the skin. Mast cell tumors may originate from other areas such as the gastrointestinal tract, spleen, liver, or mouth, but they are far more com- monly found on the skin. What are the symptoms of a mast cell tumor? Mast cell tumors on the skin can be red, hairless, and itchy. They can also feel soft or firm, and look like many other types of masses. Because they release histamine, they can grow and shrink periodically. How do you diagnose a mast cell tumor? A fine needle aspirate of the mass is performed and evaluated under a microscope for cytology. Cytology de- termines the type of tumor, however further diagnostics such as a biopsy (histopathology) are needed to further categorize or grade a mast cell tumor. What is the behavior of this type of tumor? Mast cell tumors are graded 1, 2, or 3 based on microscopic analysis of a biopsy specimen. Grade 1 tumors typically behave like benign tumors and have a low potential to spread (metastasize). Grade 3 tumors are aggressive and have a high potential to metastasize to the lymph nodes and possibly the liver, spleen, or bone marrow. Grade 2 tumors may behave either like a Grade 1 or 3 tumor. A newer grading system will determine whether a mast cell tumor is low grade or high grade. Many pathologists will use both systems to help provide as much information as possible.
    [Show full text]
  • 1.1 Antacids and Other Drugs for Dyspepsia 1.1.1 Aluminium
    1. Drugs acting on the Gastrointestinal System 1.1 Antacids and other drugs for dyspepsia 1.1.1 Aluminium- and magnesium- containing Aluminium hydroxide antacids Co-magaldrox (Mucogel®) Magnesium trisilicate 1.1.2 Antacid preparations containing simeticone Asilone® (for use in accordance with the Palliative Care Pain and Symptom Control Guidelines) 1.1.3 Other drugs for dyspepsia and gastro- Algicon® (second-line alginate) oesophageal disease Gaviscon Advance® liquid (first-line alginate) Gaviscon Infant® (Neonatal Unit only) 1.2 Antispasmodics and other drugs altering gut motility Alverine (Gastroenterology only) Dicycloverine Domperidone Hyoscine-n-butyl bromide Mebeverine Metoclopramide Peppermint oil 1.3 Ulcer-healing drugs 1.3.1 H2-receptor antagonists Cimetidine Ranitidine 1.3.3 Chelates and complexes Sucralfate 1.3.5 Proton pump inhibitors - Omeprazole capsules (first line PPI - Losec MUPS are non-formulary) see Salford PPI Strategy and Guidelines Lansoprazole orodispersible tablet (FasTab®) (for patients unable to swallow tablets) Rabeprazole (Gastroenterologists and Gastroenterology Surgeons only) 1.4 Acute diarrhoea 1.4.1 Adsorbents & bulk-forming Kaolin mixture 1.4.2 Antimotility drugs Codeine phosphate Loperamide 1.5 Chronic bowel disorders Colifoam® (hydrocortisone) Infliximab (in accordance with NICE guidance) - Follow restricted high cost drug procedure when prescribing infliximab Mesalazine Predenema® Predfoam® Predsol® Sulfasalazine Clipper® (Beclometasone dipropionate) (consultant gastroenterologist only) Budesonide Rectal
    [Show full text]
  • Acid-Reducing Medications: Interactions with Harvoni and Epclusa
    November 2016 | www.hepatitis.va.gov Acid-Reducing Medications: Interactions with Harvoni® and Epclusa® Sofosbuvir/Velpatasvir = Epclusa® Ledipasvir/Sofosbuvir = Harvoni® • Acid-reducing medications can decrease the effectiveness of Harvoni® and Epclusa® and could prevent successful cure. • Let your provider know if you are taking any acid-reducing medications—either prescribed to you or purchased over the counter. Types of Acid-Reducing What to Do if What to Do if Medications Taking Epclusa® Taking Harvoni® Antacids Separate taking the antacid and Separate taking the antacid and Epclusa® by 4 hours Harvoni® by 4 hours Combinations of aluminum, magnesium, and calcium. Brand names include: Alka-Seltzer® Maalox® Mylanta® Rolaids® TUMS® H2 Blockers Do not take more than the Do not take more than the recommended doses recommended doses Cimetidine (Tagamet®) Famotidine (Pepcid®) May take together with Epclusa® May take together with Harvoni® Nizatidine (Axid®) or 12 hours apart or 12 hours apart Ranitidine (Zantac®) Proton Pump Inhibitors (PPI) It is best to avoid PPIs during treat- It is best to avoid PPIs during ment with Epclusa®. If there are no treatment with Harvoni®. If there Esomeprazole (Nexium®) alternatives, follow these instructions: are no alternatives, follow these Lansoprazole (Prevacid®) instructions: Omeprazole (Prilosec®) Take Epclusa® with food Pantoprazole (Protonix®) Take the proton pump inhibitor 4 Take Harvoni® and the proton Rabeprazole (Aciphex®) hours after taking Epclusa® pump inhibitor at the same time in the morning after fasting overnight Do not take the proton pump (on an empty stomach) inhibitor at the same time as Epclusa® Do not take proton pump Do not take proton pump inhibitors inhibitors at more than the at more than the recommended dose recommended dose U.S.
    [Show full text]
  • Risks of Proton Pump Inhibitors for Gastroesophageal Reflux Disease and a Diet Alternative
    Journal of Nutritional Health & Food Engineering Literature Review Open Access Risks of proton pump inhibitors for gastroesophageal reflux disease and a diet alternative Abstract Volume 10 Issue 1 - 2020 Gastroesophageal reflux disease (GERD) is one of the most common digestive conditions Mark Stengler NMD treated by gastroenterologists. The most commonly prescribed drugs for GERD are proton Stengler Center for Integrative Medicine, USA pump inhibitors (PPIs) that reduce stomach acid. While these medications are effective for relieving GERD symptoms, their long-term use is associated with several side effects Correspondence: Mark Stengler NMD, Stengler Center for and chronic diseases. Several publications have questioned the long-term safety of PPIs. Integrative Medicine, 324 Encinitas Blvd. Moreover, recent studies have demonstrated that the Mediterranean Diet may be more Encinitas, CA 92024 1-760-274-2377, effective than PPIs for people suffering from GERD. Email Keywords: GERD, mediterranean diet, proton pump inhibitors, PPI, acid reflux, LES, Received: April 14, 2020 | Published: April 28, 2020 lower esophageal sphincter, omeprazole, prilosec Introduction Proton pump inhibitors to treat GERD Gastroesophageal reflux disease (GERD) is one of the most common The most commonly prescribed drugs for GERD are proton digestive conditions treated by gastroenterologists and primary care pump inhibitors (PPIs).2 PPIs currently available on prescription in doctors. Typical symptoms include heartburn, regurgitation, and the USA are: dexlansoprazole
    [Show full text]
  • Treating Heartburn and GERD
    ® Treating heartburn and GERD eartburn is a feeling of burning pain in the pit of your stomach or your lower chest. It comes from acid backing up from your stomach into your throat. You Hmay have seen ads for heartburn drugs, such as Nexium, Prilosec, or Prevacid. These drugs are called PPIs (proton pump inhibitors). They keep the stomach from making too much acid. They have been shown to heal irritation of the tube between the throat and the stomach (the esophagus). In most cases, you don’t need a PPI for heartburn. You can get relief from a less powerful drug. And when you do need a PPI, you should take the lowest dose for as short a time as possible. Here’s why: You may not need a PPI. PPIs have risks. More than half of the people who take PPIs If you need a PPI, taking a low dose for less probably do not need them. Simple heartburn than a year is probably safe. PPIs are expensive can be treated with antacids or other drugs, plus and have been linked to higher risk of some diet and lifestyle changes. problems. Talk with your doctor before taking You may only have heartburn every now and them for longer than two weeks. Be sure you then—such as after a big, spicy meal. This may have a good reason to take the PPI, and take it be uncomfortable, but it is not serious. You can for the shortest time possible. usually get relief from an antacid, like Rolaids or Tums, or an H2 blocker, such as Pepcid AC or Zantac.
    [Show full text]
  • Effects of Antacids and Food on Absorption of Famotidine
    Br. J. clin. Pharmac. (1987), 24, 551-553 Effects of antacids and food on absorption of famotidine J. H. LIN, A. N. CHREMOS, S. M. KANOVSKY, S. SCHWARTZ, K. C. YEH & J. KANN Merck Sharp and Dohme Research Laboratories, West Point, PA 19486 and Biodecision Laboratories, Inc. Pittsburgh, PA 15213, USA The effect of a high potency antacid and food on the bioavailability of famotidine was studied in 17 healthy volunteers in an open randomized three-way cross-over trial. After an overnight fast, famotidine was administered to each subject as follows: 40 mg famotidine orally alone; 40 mg orally with antacid; and 40 mg orally with a standard breakfast. Co- administration of the antacid caused a small but significant reduction in the maximum plasma concentration (Cmax) of famotidine from 81.1 ± 54.2 to 60.8 ± 21.6 ng ml-' (P < 0.05) and a small decrease in the area under plasma concentration-time curve [AUC] from 443.3 ± 249.2 to 355.0 ± 125.1 ng ml-1 h (P > 0.05). However, there was only a minimal effect of food on these parameters; the Cmax and [AUC] were 81.6 ± 29.6 ng ml-' and 434.8 ± 145.9 ng ml-' h, respectively. Keywords famotidine antacids food absorption Introduction Famotidine (3-(((2-((aminoiminomethyl)amino)- The purpose of the present study was to in- 4-thiazolyl)methyl)-thio)-N(aminosulphonyl)- vestigate the effects of a high potency antacid propanimidamide) is a new histamine H2- and food on the bioavailability and disposition of receptor antagonist. It has been reported to be famotidine.
    [Show full text]
  • Anaesthetic Antacids: a Review of Its Pharmacological Properties and Therapeutic Efficacy
    International Journal of Research in Medical Sciences Parakh RK et al. Int J Res Med Sci. 2018 Feb;6(2):383-393 www.msjonline.org pISSN 2320-6071 | eISSN 2320-6012 DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20180005 Review Article Anaesthetic antacids: a review of its pharmacological properties and therapeutic efficacy Rajendra Kumar Parakh*, Neelakanth S. Patil Department of Medicine, SDM College of Medical Sciences and Hospital, Sattur, Dharwad, Karnataka, India Received: 13 December 2017 Accepted: 27 December 2017 *Correspondence: Dr. Rajendra Kumar Parakh, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Anaesthetic antacids, combination of antacids (Aluminium hydroxide, Magnesium hydroxide) with an anaesthetic (oxethazaine), is becoming a choice of physicians and is re-emerging across all types of GI disorders (esophagitis, peptic ulcer, duodenal ulcer, heartburn, gastritis, functional dyspepsia), despite the discovery of potent and efficacious acid suppressants like H2 receptor blockers and proton pump inhibitors (PPIs). The reason being that anaesthetic antacids increase the gastric pH and provide relief from pain for a longer period of duration at considerably a lower dosage. Furthermore, it significantly increases the duration between the time of medication and the peak pH as compared to antacid alone. Oxethazaine, an anaesthetic component, produces a reversible loss of sensation and provides a prompt and prolonged relief of pain, thereby broadening the therapeutic spectrum of antacids.
    [Show full text]
  • Antacid Drug Use and Risk of Esophageal and Gastric Adenocarcinomas in Los Angeles County
    526 Antacid Drug Use and Risk of Esophageal and Gastric Adenocarcinomas in Los Angeles County Lei Duan,1 Anna H. Wu,2 Jane Sullivan-Halley,1 and Leslie Bernstein1,2 1City of Hope National Medical Center, Duarte, California and 2Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California Abstract Objectives: Concern has been expressed that antacid among persons with no UGI disorder than among drugs increase the risk of esophageal and gastric those with an UGI disorder (homogeneity of trends adenocarcinomas. P = 0.07). Regular use of nonprescription acid Methods: This population-based case-control study neutralizing agents was not associated with risk of recruited patients with incident esophageal adeno- adenocarcinomas of the gastric cardia or distal carcinoma (n = 220), gastric cardiac adenocarcinoma stomach. Regular use of prescription acid suppressive (n = 277), or distal gastric adenocarcinoma (n = 441) drugs was not associated with risk for any of these diagnosed between 1992 and 1997, and 1,356 control cancers. participants in Los Angeles County. Unconditional Conclusion: We found risk of esophageal adenocarci- polychotomous multivariable logistic regression anal- noma was greater among long-term nonprescription yses were done to evaluate the association between acid neutralizing drugs in participants without physi- antacid drug use and these cancers. cian-diagnosed UGI conditions than among those with Results: Among participants who took nonprescription these conditions; this may represent self medication for acid neutralizing agents for >3 years, the odds ratio for undiagnosed precursor conditions or it may be that esophageal adenocarcinoma was 6.32 compared with nonprescription acid neutralizing drugs, taken without P never users (95% confidence interval, 3.14-12.69; trend limitation on amount used when symptoms are most < 0.01).
    [Show full text]
  • Magnesium/Aluminum Antacids
    Magnesium/Aluminum Antacids (mag-nee-zee-um / ah-loo-mih-num) Category: Oral Antacid; Laxative (Anti-Constipation) Other Names for this Medication: Maalox®, Mylanta® Common Dosage Forms: Veterinary: None. Human: aluminum hydroxide 200 mg and magnesium hydroxide 200 mg per 5 mL oral suspension; various forms of tablets, chewable tablets, and aerosol foam suspensions. This information sheet does not contain all available information for this medication. It is to help answer commonly asked questions and help you give the medication safely and eff ectively to your animal. If you have other questions or need more information about this medication, contact your veterinarian or pharmacist. This drug SHOULD NOT be used in patients: Key Information XXThat are allergic to it. X Used to lower stomach acidity and treat stomach upset. XXThat have severe kidney disease. X Generally well tolerated; constipation or diarrhea can This drug should be used in patients: occur. WITH CAUTION XXWith electrolyte- (salt-) restricted diets, as some of these X Magnesium/aluminum antacids are available over-the- products can have significant amounts of sodium or potassium. counter (without a prescription). Do not give antacids (or any other over-the-counter medications) to your animal XXWith gastric outlet obstruction (inability of the stomach to without first talking with your veterinarian. empty). If your pet has any of these conditions, talk to your veterinarian about the potential risks versus benefits. How is this medication useful? Magnesium hydroxide with aluminum salts can lower stomach What are the side eff ects of this medication? acidity to treat a variety of conditions. The FDA (U.S.
    [Show full text]
  • "Antacids" from the WHO Model List of Essential Medicines Submitted by Abdol Majid Cheraghali ; Pharm.D.; Ph.D
    18th Expert Committee on the Selection and Use of Essential Medicines Application for the removal of "Antacids" from the WHO Model List of Essential Medicines Submitted by Abdol Majid Cheraghali ; Pharm.D.; Ph.D. Professor of Pharmacology Faculty of Medicine University of Baqiytallah Medical Science University Tehran- Iran Fax: (9821) 88601580 [email protected] Summary statement of the proposal for deletion Antacids are oral medicines to relieve heartburn, sour stomach, or acid indigestion. They work by neutralizing excess stomach acid. They mainly consist of aluminum, calcium or magnesium salts. Some antacids, such as aluminum carbonate and aluminum hydroxide, may be prescribed with a low-phosphate diet to treat hyperphosphatemia and/or to prevent the formation of some kinds of kidney stones. These medicines are widely available without a prescription. Long term use of these formulations may cause or exacerbate renal insufficiency (especially in patients with renal insufficiency) and metabolic alkalosis. Despite lack of systematic data on efficacy of these medicines, they have been used for decades in management of dyspepsia and the gastroesophageal reflux disease (GERD). However, currently most up to date clinical guidelines recommend use of proton-pump inhibitor (PPI) medicines or histamine H 2 receptor antagonists for suppression of gastric acid secretion to control symptoms and prevent complications of dyspepsia and GERD. With widespread availability and demonstrated efficacy and safety of PPIs and histamine H 2 receptor antagonists these medicines (especially PPIs) are the recommended first line antisecretary therapy in dyspepsia. Today antacids have no place in current and updated clinical guidelines for management of dyspepsia with or without H.
    [Show full text]
  • Zetia® (Ezetimibe) Tablets
    25751841T REV 03 ZETIA® (EZETIMIBE) TABLETS DESCRIPTION ZETIA (ezetimibe) is in a class of lipid-lowering compounds that selectively inhibits the intestinal absorption of cholesterol and related phytosterols. The chemical name of ezetimibe is 1-(4-fluorophenyl)- 3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone. The empirical formula is C24H21F2NO3. Its molecular weight is 409.4 and its structural formula is: OH OH S R S N F F O Ezetimibe is a white, crystalline powder that is freely to very soluble in ethanol, methanol, and acetone and practically insoluble in water. Ezetimibe has a melting point of about 163°C and is stable at ambient temperature. ZETIA is available as a tablet for oral administration containing 10 mg of ezetimibe and the following inactive ingredients: croscarmellose sodium NF, lactose monohydrate NF, magnesium stearate NF, microcrystalline cellulose NF, povidone USP, and sodium lauryl sulfate NF. CLINICAL PHARMACOLOGY Background Clinical studies have demonstrated that elevated levels of total cholesterol (total-C), low density lipoprotein cholesterol (LDL-C) and apolipoprotein B (Apo B), the major protein constituent of LDL, promote human atherosclerosis. In addition, decreased levels of high density lipoprotein cholesterol (HDL-C) are associated with the development of atherosclerosis. Epidemiologic studies have established that cardiovascular morbidity and mortality vary directly with the level of total-C and LDL-C and inversely with the level of HDL-C. Like LDL, cholesterol-enriched triglyceride-rich lipoproteins, including very-low- density lipoproteins (VLDL), intermediate-density lipoproteins (IDL), and remnants, can also promote atherosclerosis. The independent effect of raising HDL-C or lowering triglycerides (TG) on the risk of coronary and cardiovascular morbidity and mortality has not been determined.
    [Show full text]